Guizhong Li

机构：Capital Medical University, Peking University, Beijing Jishuitan Hospital, Ningxia Medical University · ORCID：0000-0001-7684-0119

发表论文 97 篇 · 总被引 1132 次 · h-index 19

代表论文

• Low-intensity extracorporeal shock wave therapy for male chronic pelvic pain syndrome: a systematic review and meta-analysis (2021 · Translational Andrology and Urology · 被引 36)
• Pitavastatin and resveratrol bio-nanocomplexes against hyperhomocysteinemia-induced atherosclerosis via blocking ferroptosis-related lipid deposition (2025 · Journal of Controlled Release · 被引 27)
• Targeted delivery of rosuvastatin enhances treatment of hyperhomocysteinemia-induced atherosclerosis using macrophage membrane-coated nanoparticles (2024 · Journal of Pharmaceutical Analysis · 被引 23)
• Comparison of transcatheter arterial chemoembolization with raltitrexed plus liposomal doxorubicin vs. tegafur plus pirarubicin for unresectable hepatocellular carcinoma (2020 · Journal of Gastrointestinal Oncology · 被引 12)
• Low-intensity extracorporeal shock wave therapy for III B chronic pelvic pain syndrome (2020 · Translational Andrology and Urology · 被引 12)
• Outcomes of early endoscopic realignment for blunt straddle injuries to the bulbar urethra: a single-center retrospective study (2022 · BMC Surgery · 被引 10)